Thermo Fisher Scientific | TMO - Заемный капитал





Заемный капитал Изменить Дата
Abbott USD 29.64B 19.74B 2026-03
Agilent USD 3.05B 1000K 2026-03
Becton, Dickinson and Co. USD 14.71B 2.21B 2026-03
Bio Techne USD 200M 60M 2026-03
Bio-Rad Laboratories USD 802.9M 398.8M 2026-03
Boston Scientific USD 11.01B 19M 2025-12
Bruker USD 1.66B 189.6M 2026-03
Charles River Laboratories USD 2.66B 526.77M 2026-03
Danaher USD 25.15B 7.59B 2026-06
Dentsply International USD 2.01B 9M 2026-03
Edwards Lifesciences USD 600M 1.7M 2026-03
General Electric Aerospace USD 17.16B 1.02B 2026-06
Henry Schein USD 2.33B 17M 2026-03
Illumina USD 1.49B 0 2026-03
Intuitive Surgical USD 0 0 2025-03
IQVIA Holdings USD 13.99B 105M 2026-03
Laboratory Of America USD 5.9B 748.3M 2026-03
Medtronic USD 27.88B 255M 2025-12
Mettler Toledo International USD 2.16B 73.35M 2026-03
Myriad Genetics USD 120.3M 400K 2026-03
Olympus JPY 159.7B 61M 2026-03
OraSure Technologies USD 100K 17K 2025-12
Quest Diagnostics USD 5.16B 12M 2026-03
Repligen USD 546.58M 4.37M 2026-03
Revvity USD 2.63B 836K 2026-03
Stryker USD 14.22B 635M 2026-03
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
Veracyte USD 0 0 2025-03
Waters USD 5.22B 3.81B 2026-03
Zimmer Biomet Holdings USD 6.3B 636.9M 2026-03